Goldman Sachs Group »

Telomir Pharmaceuticals shares owned by Goldman Sachs Group

Quarter-by-quarter ownership of Telomir Pharmaceuticals (TELO) shares owned by Goldman Sachs Group from 13F filings

Historical chart of Goldman Sachs Group investment in Telomir Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Telomir Pharmaceuticals held by Goldman Sachs Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Telomir Pharmaceuticals by Goldman Sachs Group

Quarter filed Position value Share count Share price at filing
2025-09-30 $32k 23k 1.39
2025-03-31 $104k 32k 3.23
2024-12-31 $208k 51k 4.12

More positions owned by Goldman Sachs Group

Nvidia Corporation CMN (NVDA)
Spdr S&p 500 Etf Tr CMN (SPY)
Microsoft Corp CMN (MSFT)
Apple CMN (AAPL)
Invesco Qqq Tr CMN Put Option (QQQ)
Tesla CMN (TSLA)
Amazon CMN (AMZN)
Meta Platforms CMN (META)
Alphabet CMN (GOOGL)
Broadcom CMN (AVGO)
Ishares Tr CMN (IVV)
Ishares Tr CMN Put Option (IWM)
Vanguard Index Fds CMN (VOO)
Ishares Tr CMN Put Option (HYG)
Jpmorgan Chase & Co. CMN (JPM)

View all positions for Goldman Sachs Group

Top funds holding Telomir Pharmaceuticals

Vanguard Group
BlackRock
Millennium Management
Geode Capital Management
Raymond James Financial
UBS Group
State Street Corporation
Bank of New York Mellon
Suncoast Equity Management
Northern Trust
Morgan Stanley
Advisor Group Holdings
Resources Investment Advisors
Goldman Sachs Group
Praetorian Wealth Management

View all funds holding Telomir Pharmaceuticals